Association between use of benzodiazepines and risk of fractures: a meta-analysis

Opioids, antiepileptic and anticholinergic drugs and the risk of fractures in patients 65 years of age and older: a prospective population-based study

(2012) J. Nurminen et al.   AGE AND AGEING

Tricyclic antidepressant use and risk of fractures: A meta-analysis of cohort and case-control studies

(2012) Qing Wu et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Relationship between use of antidepressants and risk of fractures: a meta-analysis

(2012) V. Rabenda et al.   OSTEOPOROSIS INTERNATIONAL

Brains, Bones, and Aging: Psychotropic Medications and Bone Health Among Older Adults

(2012) Monique J. Brown et al.   Current Osteoporosis Reports

Association of Antiepileptic Drugs With Nontraumatic Fractures

(2011) Nathalie Jetté et al.   ARCHIVES OF NEUROLOGY

Improving the use of benzodiazepines-Is it possible? A non-systematic review of interventions tried in the last 20 years

(2010) Alesha J Smith et al.   BMC HEALTH SERVICES RESEARCH

Psychotropic drugs and the risk of fractures in old age: a prospective population-based study

(2010) Janne Nurminen et al.   BMC PUBLIC HEALTH

Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses

(2010) Andreas Stang   EUROPEAN JOURNAL OF EPIDEMIOLOGY

Impact of drug interactions, dosage, and duration of therapy on the risk of hip fracture associated with benzodiazepine use in older adults

(2010) Kristina Zint et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

(2009) David Moher et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Fracture Risk From Psychotropic Medications

(2009) James M. Bolton et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Benzodiazepine and Risk of Hip Fractures in Older People: A Nested Case-Control Study in Taiwan

(2008) Chia-Ming Chang et al.   AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY

Population-based study of the effectiveness of bone-specific drugs in reducing the risk of osteoporotic fracture

(2008) Sylvie Perreault et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY